Phan , T L , Lautenschlager , I , Razonable , R R & Munoz , F M 2018 , ' HHV-6 in liver transplantation : A literature review ' , Liver International , vol. 38 , no. 2 , pp. 210-223 . https://doi.org/10.1111/liv.13506
Title: | HHV-6 in liver transplantation : A literature review |
Author: | Phan, Tuan L.; Lautenschlager, Irmeli; Razonable, Raymund R.; Munoz, Flor M. |
Contributor organization: | Medicum Department of Virology Clinicum University of Helsinki |
Date: | 2018-02 |
Language: | eng |
Number of pages: | 14 |
Belongs to series: | Liver International |
ISSN: | 1478-3223 |
DOI: | https://doi.org/10.1111/liv.13506 |
URI: | http://hdl.handle.net/10138/233489 |
Abstract: | Human herpesvirus 6 (HHV-6A and HHV-6B) can cause primary infection or reactivate from latency in liver transplant recipients, which can result in a variety of clinical syndromes, including fever, hepatitis, encephalitis and higher rates of graft dysfunction as well as indirect effects including increased risks of mortality, CMV disease, hepatitis C progression and greater fibrosis scores. Although HHV-6 infection is currently diagnosed by quantifying viral DNA in plasma or blood, biopsy to demonstrate histopathological effects of HHV-6 remains the gold standard for diagnosis of end-organ disease. HHV-6 reactivation may be restricted to the infected organ with no evidence of active infection in the blood. HHV-6 infections in liver transplant patients are mostly asymptomatic, but clinically significant tissue-invasive infections have been treated successfully with ganciclovir, foscarnet or cidofovir. Inherited chromosomally integrated HHV-6 (ciHHV-6), in either the recipient or the donor organ, may create confusion about systemic HHV-6 infection. Recipients with inherited ciHHV-6 may have an increased risk of opportunistic infection and graft rejection. This article reviews the current scientific data on the clinical effects, risk factors, pathogenesis, diagnosis and treatment of HHV-6 infections in liver transplant recipients. |
Subject: |
chromosomally integrated HHV-6 (CIHHV-6)
human herpesvirus 6 (HHV-6) liver transplantation HUMAN-HERPESVIRUS 6 HEPATITIS-C VIRUS POLYMERASE-CHAIN-REACTION PRIMARY HUMAN-HERPESVIRUS-6 INFECTION INTEGRATED HUMAN HERPESVIRUS-6 SOLID-ORGAN CLINICAL-SIGNIFICANCE DONOR BIOPSIES RECIPIENTS CYTOMEGALOVIRUS 3111 Biomedicine |
Peer reviewed: | Yes |
Usage restriction: | openAccess |
Self-archived version: | publishedVersion |
Total number of downloads: Loading...
Files | Size | Format | View |
---|---|---|---|
Phan_et_al_2018_Liver_International.pdf | 460.0Kb |
View/ |